Tag: Kisunla

UK’s NICE Says Alzheimer’s Disease Drug Kisunla Is Not Cost-Effective

The Alzheimer's disease drug Kisunla (donanemab) recently received approval from the United Kingdom medicines authority, following the U.S.…